REFERENCES
- Carr R. L. Evaluating flow properties of solids. Chem. Engg. 1965; 72: 163–168
- Ganderton D., Kassem N. M. Dry powder inhalers. Advances in Pharmaceutical Sciences, D. Ganderton, T. Jones. Informa UK Ltd, London 1992; 6: 165–191
- Gibaldi M., Perri D. Pharmacokinetics 2nd. Informa UK Ltd, New York 1982
- Hickey A. J., Concession N. M., Van Oort N. M., Platz R. M. Factors influencing the dispersion of dry powders as aerosols. Pharm. Tech. 1994; 8: 58–82
- Hickey J. H., Gonda I., Irwin W. J., Fildes F. J. T. Factors influencing the dispersion of dry powders as aerosols. J. Pharm. Sci. 1990; 79: 1009–1014
- Hindle M., Byron P. R. Dose emissions from marketed inhalers. Int. J. Pharm. 1995; 116: 169–177
- Hinds W. C. Adhesion of particles. Aerosol Technology: Properties, Behaviour and Airborne Particles, W. C. Hinds. Informa UK Ltd, New York 1982; 127–132
- Hyvärinen A., Nike E. A. Specific determination of blood glucose with O-toluidine. Clin Chim Acta 1962; 7: 142–143
- Joshi M. R., Misra A. N. Dry powder inhalation of liposomal ketotifen fumarate: Formulation and characterization. Int. J. Pharm. 2003; 223: 15–27
- Mahesh Kumar T., Misra A. N. Influence of absorption promoters on pulmonary insulin bioactivity. AAPS Pharm. Sci. Tech. 2003; 4(2)127–138
- Niven R. W. Delivery of biotherapeutics by inhalation aerosol. Crit. Rev. Ther. Drug Carrier Syst. 1995; 12: 151–231
- Patton J. S., Trinchero P., Platz R. M. Bioavailability of pulmonary delivered peptide and protein: interferon alpha, calcitonin and parathyroid hormones. J. Cont. Rel. 1994; 28: 79–85
- Pitcairn G., Langhetti G., Ventura P., Newman S. W. A comparison of the lung deposition of salbutamol inhaled from a new dry powder inhaler at two inhaled flow rates. Int. J. Pharm. 1994; 102: 11–18
- Prime D., Atkins P. J., Slater A., Sumby B. Review of dry powder inhalers. Adv. Drug Del. Rev. 1997; 5: 1–58
- Smith P. L. Peptide delivery via the pulmonary route: a valid approach for local and systemic delivery. J. Control. Rel. 1997; 46: 99–106
- Srichana T. Protein deposition from dry powder inhalers: fine particle multiplet's as performance modifiers. Pharm. Res. 1998; 15(4)562–569
- Srichana T., Martin G. P., Marriott C. The effect of device design on drug deposition from dry powder inhaler formulations determined in vitro at different flow rates. Proc. Drug Deliv. Lungs. Aerosol Soc. Bristol. 1986; 7: 36–39
- Staniforth J. N., Rees J. E., Lai F. K., Hersey J. A. Interparticle forces in binary and ternary ordered powder mixes. J. Pharm. Pharmacol. 1982; 34: 141–145
- Stanley S. D. Delivery of peptide and non-peptide drugs through the respiratory tract. Pharm. Sci. Tech. Today 1999; 12: 450–459
- Wall D. A. Pulmonary absorption of peptides and proteins. Drug Del. 1995; 2: 1–20